donepezil has been researched along with sb 202190 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Garabadu, D; Semwal, BC | 1 |
1 other study(ies) available for donepezil and sb 202190
Article | Year |
---|---|
5-N-ethyl Carboxamidoadenosine Stimulates Adenosine-2b Receptor-Mediated Mitogen-Activated Protein Kinase Pathway to Improve Brain Mitochondrial Function in Amyloid Beta-Induced Cognitive Deficit Mice.
Topics: Adenosine A2 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognition Disorders; Disease Models, Animal; Donepezil; Drug Evaluation, Preclinical; Humans; Imidazoles; Injections, Intraventricular; Male; Maze Learning; Mice; Mitochondria; Morris Water Maze Test; Nootropic Agents; Peptide Fragments; Pyridines; Random Allocation; Specific Pathogen-Free Organisms | 2020 |